Active site of brain Zn2+-glycerophosphocholine cholinephosphodiesterase and regulation of enzyme activity

Neurochemical Research

Volumn 23, Issue 8, 1998, Pages 1061-1067

  Sok, Dai Eun ^a  

^a Chungnam National University   (South Korea)

Author keywords

Activation; Active site; Glycerophosphocholine; Inhibition; Phosphodiesterase

Indexed keywords

GLYCEROPHOSPHOCHOLINE PHOSPHODIESTERASE;

ARTICLE; BRAIN; CATTLE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL;

ALLOSTERIC REGULATION; ANIMALS; ARGININE; BINDING SITES; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; CATALYSIS; CATIONS, DIVALENT; CATTLE; CHOLINE; CYSTEINE; ENZYME ACTIVATION; GLYCEROL; HYDROGEN-ION CONCENTRATION; OXIDATION-REDUCTION; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLCHOLINE; PROTEIN BINDING; TETRANITROMETHANE; ZINC;

EID: 0031826412     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020755918632     Document Type: Article

References (19)

1. Blusztajn, J. K., Gonzalez-Coviela, I. L., Logue, M., Growdon, J. H., and Wurtman, R. J. 1990. Levels of phospholipid intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Brain Res. 536:240-244.
2. Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., and Wurtman, R. J. 1992. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA. 89:1671-1975.
3. Arba, R. M., and Quinn, P. J. 1975. A novel pathway for phosphatidylcholine catabolism in rat brain homogenates. Biochim. Biophys. Acta 380:436-441.
4. Kanfer, J. N., and McCartncy, D. G. 1989. Glycerophosphorylcholine phosphocholine phosphodiesterase activity of rat brain myelin. J. Neurosci. Res. 24:231-240.
5. Janzen, L., Tourtellotte, W. W., and Kanfer, J. N. 1990. Glycerylphosphocholine phosphocholine phosphodiesterase activity is reduced in multiple sclerosis plaques. Exp. Neurol. 109:243-246.
6. Yuan, J., and Kanfer, J. N. 1994. Purification and properties of a glycerophosphocholine phosphodiesterase from bovine brain myelin. Neurochem. Res. 19:43-48.
7. 2+-requiring glycerophosphocholine cholinephosphodiesterase possessing p-nitrophenylphosphocholine phosphodiesterase activity. Biochem. J. 286:435-440.
8. 2+-glycerophosphocholine cholinephosphodiesterase from bovine brain membranes. Neurochem. Res. 21:1193-1199.
9. 2+-glycerophosphocholine cholinephosphodiesterase by thiols and tellurites. Neurochem. Res. 20:151-157.
10. 2+-glycerophosphorylcholine phosphocholine phosphodiesterase using p-nitrophenylphosphorylcholine. Anal. Biochem. 203:201-205.
11. Wetterholm, A., and Haeggstrom, J. Z. 1992. Leukotriene A hydrolase: an anion activated peptidase. Biochim. Biophys. Acta. 1123:275-281.
12. Janeway, C. M. L., Xu, X., Murphy, J. E., Chaidaroglou, A., and Kantrowitz, E. R. 1993. Magnesium in the active site of Escherichia coli alkaline phosphatase is important for both structural stabilization and catalysis. Biochemistry 32:1601-1609.
13. Page, J. D., and Wilson, I. B. 1985. Acetylcholinesterase: Inhibition by tetranitromethane and arsenate. J. Biol. Chem. 260: 1475-1478.
14. Sun, W., and Dunford, H. B. 1993. Kinetics and mechanism of the peroxidase-catalyzed iodination of tyrosine. Biochemistry. 32: 1324-1331.
15. Coleman, J. E., and Gettins, P. 1984. Alkaline phosphatase, solution structure, and mechanism. Method. Enzymol. 107:381-452.
16. Ansell, G. B., and Spanner, S. 1975. The origin and metabolism of brain choline. In Cholinergic Mechanisms, eds. Waser, P. G., Raven Press. New York. pp. 117-129.
17. 2+) in the brains of epileptogenic and normal mice. Brain Res. 280:323-334.
18. Ames, B. N., Shigenage, M. K., and Hagen, T. M. 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:7915-7922.
19. Yim, M. B., Kang, J.-H., Yim, H.-S., Kwak, H.-S., Chock, P. B., and Stadtman, E. R. 1996. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 93:5709-5714.